|
GB201308485D0
|
|
Location based real time marketing
|
|
GB0822016D0
|
|
Treatment of metastatic cancer
|
|
GB0822022D0
|
|
Neuropathic pain
|
|
GB0822018D0
|
|
Prevention of metastatic cancer
|
|
GB0822017D0
|
|
Neuroprotective treatment
|
|
GB0822020D0
|
|
Uses of clenbuterol
|
|
GB0822021D0
|
|
Neuroprotection
|
|
GB0822019D0
|
|
Treatment for neuropathic pain
|
|
GB0705205D0
|
|
Treatment of metastatic cancer
|
|
GB0705207D0
|
|
Treatment for neuropathic pain
|
|
GB0705204D0
|
|
Uses of (S)-clenbuterol
|
|
GB0705206D0
|
|
Neuroprotective treatment
|
|
GB0618364D0
|
|
Improved use of glucocorticosteroids
|
|
GB0618363D0
|
|
Improved use of anti-inflammatory glucocorticosteroids
|
|
GB0616600D0
|
|
Treatment for neuropathic pain
|
|
GB0615506D0
|
|
Prevention of metastatic cancer
|
|
GB0615505D0
|
|
Neuropathic pain
|
|
GB0615504D0
|
|
Neuroprotection
|
|
GB0613314D0
|
|
Prevention of metastatic cancer
|
|
GB0512573D0
|
|
Improved use of anti-inflammatory glucocorticosteroids
|
